JPMorgan Chase Raises MetLife Target Price, Potential Upside Hits 11.56%

MetLife's (NYSE:MET) stock price may see an increase according to JPMorgan Chase & Co., which raised its target price from $106.00 to $108.00 in a recent note.

The firm currently has an 'overweight' rating on the financial services provider's stock, suggesting a potential upside of 11.56% from the previous close of $96.81.

This is not the first time analysts have increased their target price for MetLife. In July and August, other firms such as Jefferies Financial Group, Barclays, Atlantic Securities, TD Cowen, and Morgan Stanley also raised their targets on shares of MET.